JPMorgan Chase & Co’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,466
| Closed | -$160K | – | 6106 |
|
|
2022
Q1 | $160K | Buy |
7,466
+723
| +11% | +$15.5K | ﹤0.01% | 4548 |
|
|
2021
Q4 | $227K | Buy |
6,743
+5,584
| +482% | +$188K | ﹤0.01% | 4473 |
|
|
2021
Q3 | $30K | Sell |
1,159
-1,075
| -48% | -$27.8K | ﹤0.01% | 5072 |
|
|
2021
Q2 | $31K | Buy |
2,234
+219
| +11% | +$3.04K | ﹤0.01% | 5054 |
|
|
2021
Q1 | $21K | Sell |
2,015
-62
| -3% | -$646 | ﹤0.01% | 4941 |
|
|
2020
Q4 | $17K | Sell |
2,077
-1,264
| -38% | -$10.3K | ﹤0.01% | 4608 |
|
|
2020
Q3 | $25K | Buy |
3,341
+888
| +36% | +$6.65K | ﹤0.01% | 4450 |
|
|
2020
Q2 | $22K | Buy |
2,453
+1,984
| +423% | +$17.8K | ﹤0.01% | 4402 |
|
|
2020
Q1 | $4K | Sell |
469
-231
| -33% | -$1.97K | ﹤0.01% | 4552 |
|
|
2019
Q4 | $10K | Sell |
700
-2,500
| -78% | -$35.7K | ﹤0.01% | 4502 |
|
|
2019
Q3 | $50K | Buy |
+3,200
| New | +$50K | ﹤0.01% | 4260 |
|